IR-Med Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 4.73 million compared to USD 3.72 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.06 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.585 USD | -4.68% | -35.00% | -49.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.13% | 40.94M | |
-6.74% | 180B | |
+3.16% | 112B | |
-3.41% | 68.53B | |
+5.45% | 51.97B | |
+5.64% | 44.08B | |
+5.62% | 42.23B | |
+24.22% | 32.43B | |
+16.72% | 26.39B | |
-3.58% | 24.97B |
- Stock Market
- Equities
- IRME Stock
- News IR-Med Inc.
- IR-Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2022